45Indexed trials
mesh condition
Neoplasms
Intelligence
Neoplasms intelligence: 45 indexed trials, 9 recruiting studies, 41 sponsors across 26 countries.
9Recruiting
41Sponsors
26Countries
Leading sponsors
GlaxoSmithKline20 recruiting
King's College London20 recruiting
Medical University of South Carolina22 recruiting
Merck Sharp & Dohme LLC21 recruiting
Eisai Inc.10 recruiting
Eli Lilly and Company10 recruiting
CHU de Reims10 recruiting
Hospital Clinic of Barcelona10 recruiting
Constellation Pharmaceuticals10 recruiting
Hospital Universitario La Fe10 recruiting
Institut Català d'Oncologia10 recruiting
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau10 recruiting
Geographic activity
United States20trials
Spain7trials
United Kingdom6trials
France4trials
Netherlands4trials
Denmark2trials
Chile2trials
Canada2trials
Germany2trials
Hong Kong2trials
Puerto Rico2trials
Italy1trials
Leading interventions
Carboplatin2trials
AZD74511trials
Cetuximab1trials
Brain Health Workshop (BHW)1trials
Donepezil hydrochloride1trials
Caregivers-patients support intervention for advanced cancer (CASA)1trials
Behavioral Activation Therapy App1trials
Control group1trials
Dexmedetomidine1trials
Digital storytelling1trials
ADSMP-C1trials
5 Love Languages1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.